Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MORRISVILLE, N.C., May 22, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
-
MORRISVILLE, N.C., May 13, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
-
Highlights GAAP revenue of $1,163.4 million for the three months ended March 31, 2020, representing growth of 4.0%, 3.8% on an adjusted basis, and 4.4% on a constant currency adjusted basis compared...
-
Company Expects Aggregate First Quarter Results to Be in Line With Previously Issued Guidance Range First Quarter 2020 Earnings Call Scheduled for Thursday, April 30, 2020 MORRISVILLE, N.C., April ...
-
Alongside ACRO, Syneos Health to Provide Support for COVID-19 Testing Centers;Company Continues Public Service Educational Program to Address Ventilator Shortage MORRISVILLE, N.C., April 03, 2020 ...
-
www.COVID-BiPAPInfo.com Provides Practical Information for Physicians on Innovative Use of BiPAP Machines – Already Available in Many Hospitals – to Potentially Delay or Remove Need for Mechanical...
-
Highlights GAAP revenue of $1,213.0 million and $4,675.8 million for the three and twelve months ended December 31, 2019, representing growth of 5.9% and 6.5% compared to the same periods in 2018,...
-
MORRISVILLE, N.C., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end...
-
MORRISVILLE, N.C., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced a strategic collaboration and...
-
MORRISVILLE, N.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...